IMAX CORP (IMAX) Stock Fundamental Analysis
NYSE:IMAX - New York Stock Exchange, Inc. - CA45245E1097 - Common Stock - Currency: USD
Taking everything into account, IMAX scores 4 out of 10 in our fundamental rating. IMAX was compared to 72 industry peers in the Entertainment industry. IMAX has only an average score on both its financial health and profitability. IMAX has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
IMAX had positive earnings in the past year.
In the past year IMAX had a positive cash flow from operations.
In multiple years IMAX reported negative net income over the last 5 years.
IMAX had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
IMAX has a Return On Assets of 2.96%. This is in the better half of the industry: IMAX outperforms 75.00% of its industry peers.
IMAX has a better Return On Equity (8.38%) than 77.78% of its industry peers.
IMAX's Return On Invested Capital of 6.11% is fine compared to the rest of the industry. IMAX outperforms 75.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IMAX is significantly below the industry average of 22.90%.
The last Return On Invested Capital (6.11%) for IMAX is above the 3 year average (4.23%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.96% | ||
| ROE | 8.38% | ||
| ROIC | 6.11% |
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
1.3 Margins
IMAX's Profit Margin of 6.98% is amongst the best of the industry. IMAX outperforms 80.56% of its industry peers.
In the last couple of years the Profit Margin of IMAX has declined.
The Operating Margin of IMAX (14.59%) is better than 84.72% of its industry peers.
In the last couple of years the Operating Margin of IMAX has declined.
IMAX has a better Gross Margin (54.62%) than 62.50% of its industry peers.
IMAX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.59% | ||
| PM (TTM) | 6.98% | ||
| GM | 54.62% |
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IMAX is destroying value.
IMAX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, IMAX has less shares outstanding
IMAX has a worse debt/assets ratio than last year.
2.2 Solvency
IMAX has an Altman-Z score of 2.00. This is not the best score and indicates that IMAX is in the grey zone with still only limited risk for bankruptcy at the moment.
IMAX has a Altman-Z score of 2.00. This is in the better half of the industry: IMAX outperforms 65.28% of its industry peers.
The Debt to FCF ratio of IMAX is 3.90, which is a good value as it means it would take IMAX, 3.90 years of fcf income to pay off all of its debts.
IMAX has a Debt to FCF ratio of 3.90. This is in the better half of the industry: IMAX outperforms 75.00% of its industry peers.
A Debt/Equity ratio of 0.77 indicates that IMAX is somewhat dependend on debt financing.
IMAX's Debt to Equity ratio of 0.77 is in line compared to the rest of the industry. IMAX outperforms 40.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 3.9 | ||
| Altman-Z | 2 |
ROIC/WACC0.48
WACC12.85%
2.3 Liquidity
IMAX has a Current Ratio of 1.50. This is a normal value and indicates that IMAX is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of IMAX (1.50) is better than 68.06% of its industry peers.
A Quick Ratio of 1.31 indicates that IMAX should not have too much problems paying its short term obligations.
IMAX has a Quick ratio of 1.31. This is in the better half of the industry: IMAX outperforms 65.28% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.31 |
3. Growth
3.1 Past
The earnings per share for IMAX have decreased by 0.00% in the last year.
IMAX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.17% yearly.
IMAX shows a decrease in Revenue. In the last year, the revenue decreased by -1.99%.
The Revenue has been decreasing by -2.30% on average over the past years.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%-13.33%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%9.53%
3.2 Future
Based on estimates for the next years, IMAX will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.83% on average per year.
Based on estimates for the next years, IMAX will show a small growth in Revenue. The Revenue will grow by 7.11% on average per year.
EPS Next Y21.71%
EPS Next 2Y19.4%
EPS Next 3Y15.83%
EPS Next 5Y13.83%
Revenue Next Year11.64%
Revenue Next 2Y8.4%
Revenue Next 3Y7.11%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 31.05 indicates a quite expensive valuation of IMAX.
Based on the Price/Earnings ratio, IMAX is valued a bit cheaper than 76.39% of the companies in the same industry.
IMAX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.31.
IMAX is valuated rather expensively with a Price/Forward Earnings ratio of 21.32.
Based on the Price/Forward Earnings ratio, IMAX is valued a bit cheaper than 75.00% of the companies in the same industry.
IMAX is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.05 | ||
| Fwd PE | 21.32 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IMAX is valued a bit cheaper than the industry average as 70.83% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, IMAX is valued a bit cheaper than the industry average as 76.39% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.65 | ||
| EV/EBITDA | 15.03 |
4.3 Compensation for Growth
IMAX's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
IMAX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as IMAX's earnings are expected to grow with 15.83% in the coming years.
PEG (NY)1.43
PEG (5Y)N/A
EPS Next 2Y19.4%
EPS Next 3Y15.83%
5. Dividend
5.1 Amount
No dividends for IMAX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
28.88
+0.28 (+0.98%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners91.65%
Inst Owner Change1.82%
Ins Owners19.4%
Ins Owner Change0.97%
Market Cap1.55B
Analysts80
Price Target31.71 (9.8%)
Short Float %13.11%
Short Ratio5.39
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.74%
Min EPS beat(2)-6.42%
Max EPS beat(2)11.91%
EPS beat(4)3
Avg EPS beat(4)49.12%
Min EPS beat(4)-6.42%
Max EPS beat(4)138.86%
EPS beat(8)7
Avg EPS beat(8)74.71%
EPS beat(12)8
Avg EPS beat(12)23.52%
EPS beat(16)11
Avg EPS beat(16)18.84%
Revenue beat(2)1
Avg Revenue beat(2)-5.16%
Min Revenue beat(2)-11.37%
Max Revenue beat(2)1.04%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-11.37%
Max Revenue beat(4)14.74%
Revenue beat(8)4
Avg Revenue beat(8)1.2%
Revenue beat(12)6
Avg Revenue beat(12)1.21%
Revenue beat(16)8
Avg Revenue beat(16)3.18%
PT rev (1m)1.6%
PT rev (3m)3.64%
EPS NQ rev (1m)3.35%
EPS NQ rev (3m)-1.42%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.75%
Revenue NQ rev (1m)0.64%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.05 | ||
| Fwd PE | 21.32 | ||
| P/S | 4.31 | ||
| P/FCF | 21.65 | ||
| P/OCF | 17.49 | ||
| P/B | 5.18 | ||
| P/tB | 7.72 | ||
| EV/EBITDA | 15.03 |
EPS(TTM)0.93
EY3.22%
EPS(NY)1.35
Fwd EY4.69%
FCF(TTM)1.33
FCFY4.62%
OCF(TTM)1.65
OCFY5.72%
SpS6.69
BVpS5.57
TBVpS3.74
PEG (NY)1.43
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.96% | ||
| ROE | 8.38% | ||
| ROCE | 7.71% | ||
| ROIC | 6.11% | ||
| ROICexc | 7.12% | ||
| ROICexgc | 10.94% | ||
| OM | 14.59% | ||
| PM (TTM) | 6.98% | ||
| GM | 54.62% | ||
| FCFM | 19.93% |
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
ROICexc(3y)4.84%
ROICexc(5y)N/A
ROICexgc(3y)7.01%
ROICexgc(5y)N/A
ROCE(3y)5.33%
ROCE(5y)N/A
ROICexcg growth 3Y113.18%
ROICexcg growth 5Y-5.75%
ROICexc growth 3Y103.14%
ROICexc growth 5Y-8.28%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
F-Score4
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 3.9 | ||
| Debt/EBITDA | 1.99 | ||
| Cap/Depr | 27.12% | ||
| Cap/Sales | 4.74% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 76.92% | ||
| Profit Quality | 285.52% | ||
| Current Ratio | 1.5 | ||
| Quick Ratio | 1.31 | ||
| Altman-Z | 2 |
F-Score4
WACC12.85%
ROIC/WACC0.48
Cap/Depr(3y)25.16%
Cap/Depr(5y)18.94%
Cap/Sales(3y)4.33%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%-13.33%
EPS Next Y21.71%
EPS Next 2Y19.4%
EPS Next 3Y15.83%
EPS Next 5Y13.83%
Revenue 1Y (TTM)-1.99%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%9.53%
Revenue Next Year11.64%
Revenue Next 2Y8.4%
Revenue Next 3Y7.11%
Revenue Next 5YN/A
EBIT growth 1Y-4.8%
EBIT growth 3Y108.21%
EBIT growth 5Y-9.36%
EBIT Next Year233.22%
EBIT Next 3Y52.46%
EBIT Next 5Y31.14%
FCF growth 1Y149.83%
FCF growth 3YN/A
FCF growth 5Y-7.57%
OCF growth 1Y109.83%
OCF growth 3Y126.45%
OCF growth 5Y-4.76%